Jeevan Scientific Technology Limited has submitted a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company successfully completed an inspection conducted by the Central Drugs Standard Control Organization (CDSCO), Hyderabad Zonal Office, at its Bioavailability/Bioequivalence (BA/BE) Study Centre located at Plot No. B-17, TIE Phase II, Balanagar, Hyderabad-500037, India. The inspection was completed on June 24, 2026.
The inspection was undertaken pursuant to the company's application seeking approval for addition of beds to its existing approved BA/BE Study Centre. The inspection was conducted as part of the regulatory evaluation process to assess compliance with applicable guidelines and requirements. The company extended full cooperation to the inspection team during the course of the inspection.